Skin cancer screening in adults

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From Tier Table Database

CDC Office of Public Health Genomics (OPHG) conducts horizon scanning (a systematic research method to find and follow novel technologies appearing in the literature) to identify and track the progress of genomic tests as they move from research into clinical and public health practice. As an aid in organizing horizon scanning results, OPHG ranks genomic tests, and family health history applications, by levels of evidence. See detail.

---

Disease/Disorder	Test to be Assessed	Intended Use	Tier Classified	Detail
Skin cancer screening in adults	Family history of skin cancer	Risk prediction	Tier 2
Unresectable or metastatic melanoma	G6PD	Pharmacogenomic for dabrafenib	Tier 2
Unresectable or metastatic melanoma	BRAF V600E	Pharmacogenomic for vemurafenib	Tier 1
Unresectable or metastatic melanoma	BRAF V600E	Pharmacogenomic for dabrafenib	Tier 1
Unresectable or metastatic melanoma	BRAF V600E/K	Pharmacogenomic for trametinib	Tier 1

more